John Young
Director/Board Member at JOHNSON CONTROLS INC
Net worth: 1 M $ as of 2024-03-30
John Young active positions
| Companies | Position | Start | End |
|---|---|---|---|
| JOHNSON CONTROLS INTERNATIONAL PLC | Director/Board Member | 2017-11-30 | - |
| Independent Dir/Board Member | 2017-11-30 | - | |
| JOHNSON CONTROLS INC | Director/Board Member | - | - |
| ARVINAS, INC. | Director/Board Member | 2022-08-17 | - |
| Independent Dir/Board Member | 2022-08-17 | - | |
| NOVARTIS AG | Director/Board Member | 2023-03-06 | - |
| Independent Dir/Board Member | 2023-03-06 | - | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Director/Board Member | 2022-03-23 | - |
| Life Sciences Council | Corporate Officer/Principal | - | - |
| Ministerial Industry Strategy Group | Corporate Officer/Principal | 2007-12-31 | - |
| National Committee on United States-China Relations, Inc. | Corporate Officer/Principal | - | - |
Career history of John Young
Former positions of John Young
| Companies | Position | Start | End |
|---|---|---|---|
| HALEON PLC | Director/Board Member | - | 2023-02-27 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ | - | - |
Training of John Young
| University of Glasgow | Undergraduate Degree |
| Strathclyde Business School | Masters Business Admin |
Statistics
International
| United States | 9 |
| United Kingdom | 8 |
| Switzerland | 2 |
Operational
| Director/Board Member | 7 |
| Corporate Officer/Principal | 6 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 8 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ARVINAS, INC. | Health Technology |
| JOHNSON CONTROLS INTERNATIONAL PLC | Producer Manufacturing |
| HALEON PLC | Distribution Services |
| Private companies | 10 |
|---|---|
Johnson Controls, Inc.
 Johnson Controls, Inc. Packaged SoftwareTechnology Services Johnson Controls, Inc. operates as a global diversified technology and industrial business. The firm operates through the following segments: Building Efficiency, Automotive Experience and Power Solutions. The Building Efficiency segment engages in designing, producing, marketing and installing integrated heating, ventilating and air conditioning systems, building management systems, controls, security and mechanical equipment. The Automotive Experience segment provides innovative interior systems through its design and engineering expertise. The Power Solutions segment is a global supplier of lead-acid automotive batteries for passenger car, light truck and utility vehicle. It serves both automotive original equipment manufacturers and the general vehicle battery aftermarket. It also supplies batteries to power Start-Stop vehicles, as well as lithium-ion battery technologies to power certain hybrid and electric vehicles. The company was founded by Warren Seymour Johnson and William Plankinton in 1885 and is headquartered in Milwaukee, WI. | Technology Services |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
| National Committee on United States-China Relations, Inc. | |
| Ministerial Industry Strategy Group | |
Pfizer Essential Health
 Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Essential Health is an American company that manufactures pharmaceutical products. | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Health Technology |
| Life Sciences Council |
- Stock Market
- Insiders
- John Young
- Experience